Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications

Yuval Ishay, Asa Kessler, Asaf Schwarts, Yaron Ilan – 26 August 2020 – The immune response against severe acute respiratory syndrome‐corona virus 2 (SARS‐CoV‐2) is comprised of both cellular and humoral arms. While current diagnostic methods are mainly based on polymerase chain reaction, they suffer from insensitivity. Therefore, antibody‐based serologic tests are being developed to achieve higher sensitivity and specificity.

Extracellular Vesicles as a Novel Therapeutic Option in Liver Transplantation

Kristin Carlson, John Kink, Peiman Hematti, David P. Al‐Adra – 25 August 2020 – Longterm liver graft dysfunction and immunological rejection remain common adverse events, in part due to early acute rejection episodes initiated by ischemia/reperfusion injury (IRI) immediately following transplantation. Novel treatment methods are therefore required to ameliorate liver IRI and to promote longterm allograft acceptance.

Subscribe to